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ABSTRACT 
Primary non-Hodgkins lymphoma (NHL) of the breast, and its extranodal spread to the breast resulting from 
systemic lymphoma, are recognised albeit uncommon conditions. However, lymphoma involving the axilla, presenting 
with the clinical appearance of inflammatory breast carcinoma (IBC) without infiltration of breast dermal lymphatics has 
not been reported previously.  
As highlighted by the two cases presented here, this entity should be considered in the differential diagnosis of 
patients presenting with clinical IBC. The cases highlight the importance of careful histological analysis to distinguish 
IBC from NHL, since management strategies and prognosis are quite different. © 2006 Biomedical Imaging and 
Intervention Journal. All rights reserved. 
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INTRODUCTION 
Primary non-Hodgkins lymphoma (NHL) of the 
breast, and its extranodal spread to the breast as a result 
of systemic lymphoma, are recognised albeit uncommon 
conditions [1]. Primary breast lymphoma (PBL) 
comprises 0.04-0.5% of primary malignant cancers of the 
breast and 2% of all primary extranodal lymphomas [2].  
PBL should be distinguished from the cases 
presented here, since axillary lymphoma presenting with 
the clinical appearance of inflammatory breast carcinoma 
(IBC) has not been reported previously. As highlighted 
by these cases, this entity should be considered in 
differential diagnosis of patients afflicted with clinical 
IBC. The cases highlight the importance of careful 
histological confirmation in individuals presenting 
clinically as IBC, since management strategies and 
prognosis are quite different. 
CASE REPORTS 
Case 1, a female of 80 years, presented with 
productive cough, dyspnoea, ankle oedema and weight 
loss. Her medical history was otherwise largely 
unremarkable, and her performance status was poor 
ECOG (Eastern Co-operative Oncology Group – III).  
The patient had the classical clinical features of a 
left-sided IBC, including redness, heat and oedema 
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involving most of the skin of the breast, but without a 
discreet accompanying breast mass. Mammography and 
ultrasound of the breast did not detect a mass but the 
only abnormal feature was thickening of the skin over 
the involved breast, consistent with dermal oedema. 
There was an ipsilateral 2.5cm x 2.5cm x 2cm firm, 
mobile, non-tender left ipsilateral axillary lymph node 
mass. Chest radiology showed bilateral pleural effusions.  
The initial clinical diagnosis was that of IBC with 
metastatic involvement of the pleural space. Diagnostic 
and therapeutic pleural aspirations showed atypical 
lymphocytes but no malignant cells. Multiple large-bore 
needle biopsies of the skin of the left breast revealed 
dermal lymphatic ectasia with mild histiocytic 
perivascular infiltration, but no evidence of malignancy. 
The size of her axillary nodal mass increased to 7 x 5 cm 
over a four-day period and then spontaneously decreased 
to 2 x 1 cm. Interestingly, the breast oedema decreased in 
severity in parallel to the reduction in size of the nodal 
mass. Excision biopsy of the axillary lymphadenopathy 
showed a diffused lymphocytic, well-differentiated (B-
cell) non-Hodgkin’s lymphoma (Rappaport 
Classification); B-cell small lymphocytic lymphoma 
(WHO Classification). 
Investigations at this point, including gallium and 
CT scanning, and bone marrow analysis, were negative 
for involvement by lymphoma. The patient was 
commenced on chlorambucil 10 mg daily and prednisone 
60 mg daily for five days, in three-weekly cycles. After 
one cycle of chemotherapy the patient still had residual 
small bilateral pleural effusions, but her dyspnoea had 
improved considerably and her axillary adenopathy had 
completely resolved, as had the inflammatory signs in 
her breast. 
Case 2, a 74 year-old female, presented with pain in 
the left axilla and, like the first case, clinical 
inflammatory carcinoma of the left breast, without a 
palpable mass. As for Case 1, the differential diagnosis 
included cellulitis of the breast (see Discussion). Firm, 
irregular, non-tender lymph nodes were palpable in the 
left axilla (3 x 3 x 2 cm) and in the ipsilateral 
supraclavicular fossa (2 x 2 x 2 cm). The provisional 
clinical diagnosis, as in the previous patient, was IBC. 
Bilateral mammography and ultrasound were negative 
apart from apparent skin thickening. External 
examination was otherwise unremarkable. Biopsy of 
clinically-involved skin over the left breast showed a 
mild perivascular lymphocytic infiltrate, without definite 
tumour cells. A left supraclavicular fossa lymph node 
excision biopsy was performed; whose pathological 
examination showed follicular mixed NHL.  
Staging investigations at this point were negative for 
systemic lymphoma involvement. She was commenced 
on intravenous and oral chemotherapy comprising CVPP 
(cyclophosphamide 1,000 mg day 1, vincristine 2 mg day 
1, procarbazine 150 mg orally and prednisone 60 mg per 
day orally for seven days each). She received four one-
monthly cycles and achieved a complete clinical 
remission after one cycle.  
DISCUSSION 
To our knowledge, these are the only two cases of 
lymphoma involving the axilla which have clinically 
 
 
Supporting features regarding the aetiology of the clinical 
presentation of the cases reported here: 
– older  age 
– no  breast  mass 
– negative  dermal  biopsies 
–  nodal shrinkage rapidly resolved (either spontaneous or 
rapidly treatment-induced) 
 
 
Figure 1  An hypothesis for the aetiology of clinical features of inflammatory breast cancer in the cases reported 
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simulated IBC at presentation. The cases demonstrate the 
importance of careful histopathology in distinguishing 
IBC with or without axillary lymphadenopathy from 
lymphoma involving the axilla.  
It should be noted that it is only for the last decade 
or so that such clinical features of IBC have required a 
corroborating histopathological diagnosis. In the cases 
presented here, obtaining histology of the masses in the 
regional lymph node basins was essential to achieving 
correct diagnosis, as multiple cutaneous biopsies were 
negative for malignancy. The present cases should also 
be distinguished from primary breast lymphoma (PBL; 
Table 1 and Figure 1). 
The presentation of both individuals fitted the 
clinical criteria for a diagnosis of IBC, namely, signs of 
inflammation (redness, heat, induration) skin oedema 
/peau d’orange with or without tenderness, and a 
cutaneous erysipeloid edge. To fit the contemporary 
definition of IBC, these changes must be present in 
greater than one-third of the breast, as they were in these 
cases; however, a palpable mass need not necessarily be 
present [3].  
The differential diagnosis for these cases included 
cellulitis of the breast. Common features of breast 
cellulitis include a sudden onset, usually accompanied by 
constitutional symptoms such as fever and chills and 
mild cutaneous oedema; leukocytosis is usually present. 
The cases here had breast oedema but none of the other 
signs of breast cellulitis.  
Breast cellulitis typically begins in the pre-
menopausal setting and particularly during lactation [4]. 
In contrast, the cases presented here also lacked such 
features. Additionally, the size of axilliary adenopathy in 
both patients, as well as the pleural effusions in Case 1, 
was more consistent with a malignant aetiology. 
Nevertheless, the differential diagnosis of breast cellulitis 
should be entertained at least until histo- or cyto- logical 
diagnosis confirms the presence of malignant cells. 
Histologically, IBC is characterised by lymphatic 
infiltration by adenocarcinoma cells, with plugging of 
dermal lymphatics by tumour emboli. The latter are 
largely responsible for the clinical manifestations of IBC, 
secondary to lymphatic backpressure.  
In IBC, the disease spreads predominantly via 
lymphatics, and oedematous skin, and if biopsied, 
typically shows adenocarcinoma cells in the lymphatics 
[3]. It is well known that oedema of the arm and/or 
breast can occur after axillary dissection and/or 
radiotherapy to the axilla, or in advanced IDC, due to 
lymphatic disruption [5].  
Involvement of the axillary nodes by lymphoma 
could presumably also interfere with lymphatic function. 
In the two cases of axilliary lymphoma (AL) simulating 
IBC, multiple biopsies of areas of breast skin affected by 
peau d’orange failed to reveal malignant cells but simply 
showed an inflammatory cell infiltrate. We postulate that 
the oedematous, inflamed breasts in our patients were 
due to lymphatic obstruction by lymphoma in the axilla, 
with retrograde pressure build-up in lymphatics causing 
the physical signs in the breast. This finding would be 
atypical for IBC. Some other features of the two cases 
were different to IBC: one individual showed 
spontaneous regression of the axilliary nodal mass (i.e. 
prior to therapy), and lymph node masses were firm 
rather than hard (the latter expected in carcinomas) and 
both individuals had dramatic early responses to 
relatively simple chemotherapy regimens. 
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Table 1  A comparison of the clinicopathological features of inflammatory breast cancer (IBC), primary breast 
lymphoma (PBL) and axilliary lymphoma presenting as IBC (AL). IBC data was as reviewed by 
Giordano and Hortobagyi [3]; PBL data was from Gholam, et al. [1] and Maounis, et al. [2]; AL data 
was from the two cases presented here. U/K: unknown; +: typically present; -: absent. 
  IBC  PBL  AL 
Age  Spectrum: from younger to 
older 
Two peaks: younger or 
older  Older 
Palpable or 
mammographically-visible 
mass 
+/- + - 
Bilaterality  Rare Not  uncommon  U/K 
Clinical lymph node 
involvement  +/- + + 
Typical histology  Invasive ductal 
adenocarcinoma 
Younger: Burkitt or 
Burkitt-type (B-cell); 
Older: NHL, diffuse large 
(B-cell) 
B-cell small lymphocytic 
or follicular mixed NHL 
Rapid treatment response  Uncommon +  + 
 